These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30496741)

  • 21. Changes in the muscle fibre properties of the mouse temporal muscle after weaning.
    Suzuki K; Abe S; Kim HJ; Usami A; Iwanuma O; Okubo H; Ide Y
    Anat Histol Embryol; 2007 Apr; 36(2):103-6. PubMed ID: 17371381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of myosin heavy chain isoform transition in the longissimus muscle of domestic and wild pigs during growth: a comparative study.
    Fazarinc G; Vrecl M; Škorjanc D; Čehovin T; Čandek-Potokar M
    Animal; 2017 Jan; 11(1):164-174. PubMed ID: 27345286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.
    Hampton TG; Stasko MR; Kale A; Amende I; Costa AC
    Physiol Behav; 2004 Sep; 82(2-3):381-9. PubMed ID: 15276802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome.
    Cisterna B; Sobolev AP; Costanzo M; Malatesta M; Zancanaro C
    Microsc Microanal; 2020 Oct; 26(5):1014-1023. PubMed ID: 32867866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity-Dependent Dysfunction in Visual and Olfactory Sensory Systems in Mouse Models of Down Syndrome.
    William CM; Saqran L; Stern MA; Chiang CL; Herrick SP; Rangwala A; Albers MW; Frosch MP; Hyman BT
    J Neurosci; 2017 Oct; 37(41):9880-9888. PubMed ID: 28899917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial and deep layer muscle fibre properties of the mouse masseter before and after weaning.
    Shida T; Abe S; Sakiyama K; Agematsu H; Mitarashi S; Tamatsu Y; Ide Y
    Arch Oral Biol; 2005 Jan; 50(1):65-71. PubMed ID: 15598418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EMG of the digastric muscle in gibbon and orangutan: functional consequences of the loss of the anterior digastric in orangutans.
    Wall CE; Larson SG; Stern JT
    Am J Phys Anthropol; 1994 Aug; 94(4):549-67. PubMed ID: 7977679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
    Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
    Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field.
    Coussons-Read ME; Crnic LS
    Behav Genet; 1996 Jan; 26(1):7-13. PubMed ID: 8852727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.
    Sahir N; Brenneman DE; Hill JM
    J Mol Neurosci; 2006; 30(3):329-40. PubMed ID: 17401158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep Behavior and EEG Oscillations in Aged Dp(16)1Yey/+ Mice: A Down Syndrome Model.
    Levenga J; Peterson DJ; Cain P; Hoeffer CA
    Neuroscience; 2018 Apr; 376():117-126. PubMed ID: 29454635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
    Costa AC; Grybko MJ
    Neurosci Lett; 2005 Jul; 382(3):317-22. PubMed ID: 15925111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Sparsity of Hippocampal CA1 Neuronal Ensembles in a Mouse Model of Down Syndrome Assayed by Arc Expression.
    Smith-Hicks CL; Cai P; Savonenko AV; Reeves RH; Worley PF
    Front Neural Circuits; 2017; 11():6. PubMed ID: 28217086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
    Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH
    Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contractility and myosin isoform compositions of skeletal muscles and muscle cells from rats treated with thyroid hormone for 0, 4 and 8 weeks.
    Li X; Larsson L
    J Muscle Res Cell Motil; 1997 Jun; 18(3):335-44. PubMed ID: 9172075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.